Description:

This course will examine new findings pertaining to the diagnosis and management of central serious chorioretinopathy (CSCR) and what they mean for the practicing optometrist.  Key findings from recent studies will be discussed in order to provide an update on the etiology, manifestations, and pathophysiology of this condition.  We will also discuss the role of newer technologies such as enhanced depth imaging and OCT angiography on diagnosis.  Lastly, novel treatment options, including mineralocorticoid antagonist medications and subthreshold micropulse laser, will be assessed and incorporated into a current evidence-based management plan for various presentations of CSCR.

Course Code:

AOA115-PS

Speaker(s):

James Rogala, O.D.
jamesrogala@upike.edu

Credits:

1

AOA Expiration Date:

3/30/2024

Related News

How the HIPAA Privacy Rule applies in a public health emergency

In response to Hurricane Ian, the federal government takes steps to ease the pains of disaster recovery in Florida. Learn more about the federal waivers—and how you can help colleagues affected by disaster.

AOA+ aims for new heights: 3,000 in DC for ’23

Learn more about AOA+ travel grant opportunities to attend this one-of-a-kind experience for optometry students, newly graduated doctors, and educators in Washington, D.C., June 21-24, 2023.

Partners in care

The AOA has created a trove of practice management tools and services that can power practices forward in a profession and health care landscape that increasingly demands doctors practice at their highest levels and creates greater opportunities to develop and empower paraoptometric staff. These days, change is out of necessity.